Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Increase in Short Interest

Sensus Healthcare, Inc. (NASDAQ:SRTS) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,210,000 shares, a growth of 107.4% from the December 15th total of 583,500 shares. Based on an average daily volume of 203,100 shares, the short-interest ratio is currently 6.0 days. Currently, 9.2% of the shares of the stock are short sold.

Institutional Investors Weigh In On Sensus Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of SRTS. Ritholtz Wealth Management boosted its stake in shares of Sensus Healthcare by 65.3% during the fourth quarter. Ritholtz Wealth Management now owns 51,261 shares of the company’s stock valued at $355,000 after purchasing an additional 20,256 shares in the last quarter. Geode Capital Management LLC boosted its position in Sensus Healthcare by 8.5% during the 3rd quarter. Geode Capital Management LLC now owns 146,404 shares of the company’s stock worth $849,000 after buying an additional 11,525 shares during the period. XTX Topco Ltd grew its holdings in Sensus Healthcare by 76.0% during the 3rd quarter. XTX Topco Ltd now owns 31,530 shares of the company’s stock worth $183,000 after acquiring an additional 13,619 shares during the last quarter. Truvestments Capital LLC acquired a new position in Sensus Healthcare in the 3rd quarter valued at approximately $32,000. Finally, Cubist Systematic Strategies LLC bought a new position in shares of Sensus Healthcare during the second quarter valued at $156,000. Institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Stock Down 0.6 %

Shares of NASDAQ SRTS traded down $0.04 during midday trading on Thursday, reaching $6.73. 136,249 shares of the company were exchanged, compared to its average volume of 219,665. The stock’s 50-day moving average price is $7.69 and its 200-day moving average price is $6.71. The stock has a market cap of $110.30 million, a P/E ratio of 11.81 and a beta of 1.21. Sensus Healthcare has a one year low of $2.61 and a one year high of $9.33.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on SRTS shares. Maxim Group lifted their price target on Sensus Healthcare from $12.00 to $14.00 and gave the company a “buy” rating in a research note on Friday, November 15th. HC Wainwright lifted their target price on Sensus Healthcare from $10.00 to $11.00 and gave the company a “buy” rating in a research report on Monday, November 18th.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.